Jordi Pardo-Lopez
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.
Journal: The New England journal of medicine
Published: June 15, 2026
Autologous stem cell transplantation in POEMS syndrome: Multicenter real-world treatment patterns and outcomes.
Journal: Bone marrow transplantation
Published: March 02, 2026
Pomalidomide, Cyclophosphamide and Dexamethasone (PCd): Outcomes in Patients With Double- or Triple-Refractory Multiple Myeloma.
Journal: European journal of haematology
Published: November 06, 2025
Observational retrospective study of the treatment of Waldenström's macroglobulinemia with ibrutinib in routine clinical practice in Spain.
Journal: Therapeutic advances in hematology
Published: April 02, 2025
Excellent response to anti-CD38 therapy with daratumumab in a patient with severe refractory CANOMAD.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: August 22, 2023
Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma.
Journal: Bone marrow transplantation
Published: June 02, 2021
Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.
Journal: European journal of haematology
Published: September 27, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026